Polysaccharide-Modified Synthetic Polymeric Biomaterials

被引：227

作者：

Baldwin, Aaron D. ^{[1
,2
]}

Kiick, Kristi L. ^{[1
,2
]}

机构：

[1] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA

[2] Delaware Biotechnol Inst, Newark, DE 19711 USA

来源：

BIOPOLYMERS | 2010年 / 94卷 / 01期

基金：

美国国家科学基金会; 美国国家卫生研究院;

关键词：

biomaterial; polysaccharide-modified polymer; polysaccharide conjugates; hydrogel; FIBROBLAST-GROWTH-FACTOR; HEPARIN-CARRYING POLYSTYRENE; GLYCOL) STAR COPOLYMER; LACTIC-ACID OLIGOMERS; IN-VIVO ANGIOGENESIS; PEG-GRAFTED CHITOSAN; CROSS-LINKED GEL; HYALURONIC-ACID; CHONDROITIN SULFATE; CONTROLLED-RELEASE;

D O I：

10.1002/bip.21334

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

This review presents an overview of polysaccharide-conjugated synthetic polymers and their use in tissue-engineered scaffolds and drug-delivery applications. This topic will be divided into four categories: (1) polymeric materials modified with non-mammalian polysaccharides such as alginate, chitin, and dextran; (2) polymers modified with mammalian polysaccharides such as hyaluronan, chondroitin sulfate, and heparin; (3) multi-polysaccharide-derivatized polymer conjugate systems; and (4) polymers containing polysaccharidemimetic molecules. Each section will discuss relevant conjugation techniques, analysis, and the impact of these materials as micelles, particles, or hydrogels to sed in in-vitro and in-vivo biomaterial applications. (C) 2010 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 94: 128-140, 2010.

引用

页码：128 / 140

页数：13

共 181 条

[41] Anti-inflammatory drug delivery from hyaluronic acid hydrogels [J].

Hahn, SK ;

Jelacic, S ;

Maier, RV ;

Stayton, PS ;

Hoffman, AS .

JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2004, 15 (09) :1111-1119

[42] Pharmacokinetic consequences of pegylation [J].

Hamidi, Mehrdad ;

Azadi, Amir ;

Rafiei, Pedram .

DRUG DELIVERY, 2006, 13 (06) :399-409

[43] DEXTRAN AS A PLASMA SUBSTITUTE WITH PLASMA VOLUME AND EXCRETION STUDIES ON CONTROL PATIENTS [J].

HARRISON, JH .

ANNALS OF SURGERY, 1954, 139 (02) :137-142

[44] Novel crosslinking methods to design hydrogels [J].

Hennink, W. E. ;

van Nostrum, C. F. .

ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 :223-236

[45] Biodegradable dextran hydrogels crosslinked by stereocomplex formation for the controlled release of pharmaceutical proteins [J].

Hennink, WE ;

De Jong, SJ ;

Bos, GW ;

Veldhuis, TFJ ;

van Nostrum, CF .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 277 (1-2) :99-104

[46]

HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ

[47] Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels [J].

Hiemstra, Christine ;

Zhong, Zhiyuan ;

van Steenbergen, Mies J. ;

Hennink, Wim E. ;

Feijen, Jan .

JOURNAL OF CONTROLLED RELEASE, 2007, 122 (01) :71-78

[48] Rapidly in situ-forming degradable hydrogels from dextran thiols through michael addition [J].

Hiemstra, Christine ;

van der Aa, Leonardus J. ;

Zhong, Zhiyuan ;

Dijkstra, Pieter J. ;

Feijen, Jan .

BIOMACROMOLECULES, 2007, 8 (05) :1548-1556

[49] Novel in situ forming, degradable dextran hydrogels by Michael addition chemistry: Synthesis, rheology, and degradation [J].

Hiemstra, Christine ;

van der Aa, Leonardus J. ;

Zhong, Zhiyuan ;

Dijkstra, Pieter J. ;

Feijen, Jan .

MACROMOLECULES, 2007, 40 (04) :1165-1173

[50] N-ACETYLATION IN CHITOSAN AND THE RATE OF ITS ENZYMIC-HYDROLYSIS [J].

HIRANO, S ;

TSUCHIDA, H ;

NAGAO, N .

BIOMATERIALS, 1989, 10 (08) :574-576

← 1 2 3 4 5 6 7 8 9 10 →